Dr. Lisa Diller is the Chief Medical Officer, Dana-Farber Children’s Hospital Cancer Care. As a pediatric oncologist and the Clinical Director of Pediatric Oncology, she leads the joint clinical Pediatric Oncology Program at the Dana-Farber Cancer Institute and Children’s Hospital Boston. She is also the Director of the Perini Family Survivors’ Center and the David B. Perini, Jr. Quality of Life Clinic for Cancer Survivors at the Dana-Farber Cancer Institute. She is an Associate Professor of Pediatrics at Harvard Medical School.

Dr. Diller received a bachelor’s degree from Harvard University, and earned her medical degree from the University of California at San Diego. She was a resident at Children’s Hospital Boston and did her subspecialty training at Dana-Farber/Children’s Hospital Boston where she has been on the faculty for 19 years. Dr. Diller’s research focuses on the late effects of treatment for childhood cancer and genetic cancer predisposition syndromes in childhood. In addition, she investigates novel treatments for pediatric solid tumors, particularly tumors that occur in infants and toddlers.